Argitalpenak (82) JUAN MARÍA DE LA OBRA SIERRA argitalpenak

2023

  1. Analysis of retinal nerve layers in idiopathic, LRRK2-associated Parkinson's disease and unaffected carriers of G2019S mutation

    Parkinsonism and Related Disorders, Vol. 106

  2. Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™

    Neurologia, Vol. 38, Núm. 5, pp. 326-333

  3. Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease

    npj Parkinson's Disease, Vol. 9, Núm. 1

2022

  1. Sensor-based gait analysis in the premotor stage of LRRK2 G2019S-associated Parkinson's disease

    Parkinsonism and Related Disorders, Vol. 98, pp. 21-26

2021

  1. Biomonitoring and bioaccessibility of environmental airborne manganese in relation to motor function in a healthy adult population

    NeuroToxicology, Vol. 87, pp. 195-207

  2. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

    Nature Communications, Vol. 12, Núm. 1

  3. Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage

    Nature Communications, Vol. 12, Núm. 1

  4. Identification of sixteen novel candidate genes for late onset Parkinson’s disease

    Molecular Neurodegeneration, Vol. 16, Núm. 1

  5. Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease

    Annals of Neurology, Vol. 90, Núm. 1, pp. 35-42

  6. Serial DaT-SPECT imaging in asymptomatic carriers of LRRK2 G2019S mutation: 8 years’ follow-up

    European Journal of Neurology, Vol. 28, Núm. 12, pp. 4204-4208

2020

  1. Dystonia genes functionally converge in specific neurons and share neurobiology with psychiatric disorders

    Brain, Vol. 143, Núm. 9, pp. 2771-2787

  2. Escribir para gestionar, conservar para controlar: un libro registro inédito en torno a la segunda repoblación del Reino de Granada

    De scriptura et scriptis: producir

  3. Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

    The Lancet Neurology, Vol. 18, Núm. 12, pp. 1091-1102

  2. Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset

    npj Parkinson's Disease, Vol. 5, Núm. 1

  3. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability

    npj Parkinson's Disease, Vol. 5, Núm. 1

  4. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease

    Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344

  5. The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight

    Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863

  6. The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease

    Movement Disorders, Vol. 34, Núm. 4, pp. 460-468

2018

  1. LRP10 in α-synucleinopathies

    The Lancet Neurology